↓ Skip to main content

Outcomes After Off-Label Use of the Pipeline Embolization Device for Intracranial Aneurysms: A Multicenter Cohort Study

Overview of attention for article published in World Neurosurgery, April 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Outcomes After Off-Label Use of the Pipeline Embolization Device for Intracranial Aneurysms: A Multicenter Cohort Study
Published in
World Neurosurgery, April 2018
DOI 10.1016/j.wneu.2018.04.012
Pubmed ID
Authors
Abstract

The aim of this retrospective multicenter cohort study is to examine the outcomes of the Pipeline embolization device (PED) for the treatment of intracranial aneurysms outside of United States Food and Drug Administration approved (off-label) indications. Data from aneurysm patients treated with the PED for off-label indications was pooled from four different centers. The primary endpoints were decline in modified Rankin Scale (mRS) by at least 1 point and angiographic aneurysm occlusion at follow-up. The study cohort was comprised of 109 patients. The mean aneurysm size was, 20.2% were located in the posterior circulation, and 11.9% were ruptured. The most common reasons for off-label use were aneurysm size (50.5%), location (25.7%) or both (10.1%). The mean follow-up was 9 months. Complete occlusion was achieved in 82.5% of cases at last angiographic follow-up and mRS decline was found in 18.8% of the cases. On univariate analysis, age, aneurysm size aneurysm morphology, aneurysm location, and the reason for off label use as well as the rupture status were not associated with clinical decline or aneurysm occlusion on angiography. On multivariate analysis PED treatment of a ruptured aneurysm was found to be an independent predictor of a postoperative decline in mRS, and size as the only reason for off-label PED use was found to be an independent predictor of complete occlusion on final angiography. The off-label use of the PED has a reasonable risk to benefit profile for appropriately selected aneurysms. Posterior circulation location and fusiform morphology do not appear to be associated with worse clinical or angiographic outcomes.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 5 24%
Researcher 3 14%
Student > Bachelor 2 10%
Student > Ph. D. Student 2 10%
Other 1 5%
Other 4 19%
Unknown 4 19%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 10 48%
Engineering 3 14%
Agricultural and Biological Sciences 1 5%
Neuroscience 1 5%
Unknown 6 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2018.
All research outputs
#22,767,715
of 25,382,440 outputs
Outputs from World Neurosurgery
#5,801
of 7,047 outputs
Outputs of similar age
#300,675
of 340,931 outputs
Outputs of similar age from World Neurosurgery
#188
of 242 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,047 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,931 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 242 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.